Nuwellis, Inc. (NUWE)
Nuwellis, Inc. operates in the Medical - Devices industry of the Healthcare sector, headquartered in Eden Prairie, MN, US. The stock last traded at $0.78, down 3.87% on the session, giving a market capitalisation of $71,530. On trailing twelve-month figures it carries a trailing P/E of -0.01, a net margin of -123.4%. Its beta of 0.29 implies it has historically moved less than the broad market.
Nuwellis, Inc., a medical device company, develops, manufactures, and commercializes medical devices used in ultrafiltration therapy. The company provides Aquadex FlexFlow and Aquadex SmartFlow systems, which are used to treat patients suffering from fluid overload due to heart failure, as well as Aquadex SmartFlow system for temporary use in adult and pediatric patients. The company was formerly known as CHF Solutions, Inc. and changed its name to Nuwellis, Inc. in April 2021. Nuwellis, Inc. was founded in 1999 and is headquartered in Eden Prairie, Minnesota.
Nuwellis, Inc. is most often compared with the following Healthcare names: